Novomer

Photo

Danimer Buys Novomer for $152 million

US bioplastics company Danimer Scientific has agreed to pay $152 million cash for Novomer, a developer and producer of biodegradable materials. Both companies’ boards of directors have approved the deal, which is expected to close in the third quarter.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.